f.tulloch
Submits third-party assay reports on material purchased directly. Based in Coimbra.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.15%
n=10
Suppliers covered
8
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043034 | Semaglutide | KP | KP-2601-K5213 | PeptideMeter | 2026-Q2 | 98.47 | 4.69 | 100.7 | Buyer-sourced | 0 | PASS |
| AX-2026-041497 | Semaglutide | QSC | QSC-2509-Y6202 | Janoshik | 2026-Q1 | 99.18 | 4.91 | 97.6 | Buyer-sourced | 0 | PASS |
| AX-2026-042972 | MK-677 (Ibutamoren mesylate) | MKM | MKM-2509-T3949 | Nordanalyt | 2026-Q1 | 99.34 | 2.69 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-018893 | Kisspeptin-10 | TFS | TFS-{CAT}-9204 | Kestrel | 2025-Q4 | 99.60 | 3.68 | 95.8 | Buyer-sourced | 1 | FAIL |
| AX-2025-019037 | BPC-157 | ASY | ASY-{CAT}-2719 | Nordanalyt | 2025-Q4 | 99.79 | 5.17 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020533 | Semaglutide | SSA | SSA-2502-U6907 | Medutest | 2025-Q3 | 98.02 | 5.40 | 104.0 | Buyer-sourced | 0 | PASS |
| AX-2025-020374 | Ipamorelin | MKM | MKM-2504-N4424 | Janoshik | 2025-Q3 | 99.12 | 5.29 | 107.0 | Buyer-sourced | 0 | PASS |
| AX-2025-019005 | Hexarelin | ASY | ASY-{CAT}-1786 | Janoshik | 2025-Q1 | 99.91 | 4.76 | 103.5 | Buyer-sourced | 0 | PASS |
| AX-2024-004462 | Retatrutide | SinoPep | SNP-2405-T4694 | Janoshik | 2024-Q4 | 98.33 | 4.34 | 104.4 | Buyer-sourced | 0 | PASS |
| AX-2024-005350 | Tirzepatide | SIG | SIG-2404-6658 | Kestrel | 2024-Q3 | 97.79 | 8.02 | 93.9 | Buyer-sourced | 0 | FAIL |